Investor Presentaiton
EBIT margin development continues to be a function of
growth, scalability, cost discipline and investment activity
EBIT margin (%)
Illustrative
>30%
Future drivers of EBIT margin
EBIT will be positively impacted by:
+ Leverage effect on fixed costs e.g.
distribution, admin and R&D costs
especially driven by Europe
-31%
Incremental investment of up to
2% of revenue per year
Reported EBIT
margin FY 21/22
A Gross margin
Leverage
effect/scale
Incremental
investments
EBIT margin
FY 24/251
on fixed costs
1) Constant exchange rates
41
EBIT will be negatively impacted by:
Investments in P/L (Commercial & R&D)
Headwind on gross margin from increasing prices for
raw materials, energy, freight, and wage inflation in
Hungary in FY 2021/22 and FY 2022/23
ColoplastView entire presentation